Herbert Lepor, MD, NYU School of Medicine, New York, New York, discusses the advantages of identifying lesions within the prostate using MRI and then targeted focal therapy.
Keywords: prostate cancer, MRI, focal therapy
ABOUT THE AUTHOR
Dr. Herbert Lepor serves as a Professor of Urology, Biochemistry, and Molecular Pharmacology and as the Martin Spatz Chairman of the Department of Urology at NYU Langone Health in New York City. His clinical practice is devoted exclusively to the surgical management of prostate cancer. He also serves as Chairman of the Scientific Advisory Board at UroGen Pharmaceuticals, Ltd., and has served as a member of the Medical Advisory Board at Skyline Medical, Inc. He has served on the editorial boards of several major urological journals and has authored several hundred peer-reviewed articles, along with numerous book chapters and books.
